EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Abbott Laboratories's enterprise value is $206,666 Mil.
Abbott Laboratories's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was $41,217 Mil. Therefore, Abbott Laboratories's EV-to-Revenue for today is 5.01.
The historical rank and industry rank for Abbott Laboratories's EV-to-Revenue or its related term are showing as below:
ABT'
s EV-to-Revenue Range Over the Past 10 Years
Min: 2.87 Med: 4.61 Max: 7
Current: 5.01
During the past 13 years, the highest EV-to-Revenue of Abbott Laboratories was 7.00. The lowest was 2.87. And the median was 4.61.
ABT's EV-to-Revenue is ranked worse than 66.06% of 828
companies
in the Medical Devices & Instruments industry
Industry Median: 3.38
vs ABT: 5.01
The historical data trend for Abbott Laboratories's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Abbott Laboratories's EV-to-Revenue
For the Medical Devices subindustry, Abbott Laboratories's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abbott Laboratories's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Abbott Laboratories's EV-to-Revenue falls into.
Abbott Laboratories's current Enterprise Value is $206,666 Mil.
Abbott Laboratories's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $41,217 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abbott Laboratories's share price for today is $113.37.
Abbott Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $23.57.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abbott Laboratories EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Abbott Laboratories's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ABT has been successfully added to your 